September 2014

News

September 9, 2014

Janssen Inc. and Johnson & Johnson Innovation establish research collaboration with the University of Toronto – MarketWatch

Neuroscience Catalyst to Focus on Mood Disorders and Alzheimer's Disease Janssen Inc. (Janssen) today announced…

Super User 0

Love0

News

September 9, 2014

What Is Amyotrophic Lateral Sclerosis (ALS) or Lou Gehrig’s Disease? – MIT Technology Review

It’s no surprise that social-media campaigns can raise awareness of an issue, but the ALS…

Super User 0

Love0

BHI Weekly News Archives

September 9, 2014

114th Edition – September 9, 2014

You're receiving this newsletter because of your interest in BioHealth Innovation Having trouble viewing this…

Super User 0

Love0

News

September 9, 2014

BioFund passes $2 million in loans for startups in Southeast Louisiana – NOLA.com

The low-interest loan program called the BioFund has issued more than $2 million in loans to…

Super User 0

Love0

News

September 9, 2014

Where Is the Smart Venture Capital Money Going in Digital Health / Health IT?

According to CB Insights data, funding to digital health/health IT companies has already topped $2.2B…

Super User 0

Love0

News

September 9, 2014

Capital Buzz: Entrepreneurial brothers create venture capital fund – The Washington Post

Two Washington entrepreneurs with a history of building successful companies have teamed with a local…

Super User 0

Love0

News

September 9, 2014

Emergent BioSolutions Awarded Contract to Develop a Dry Formulation of NuThrax, a Next Generation Anthrax Vaccine – Seeking Alpha

Emergent BioSolutions Inc. (EBS) announced today that it has signed a contract with the National…

Super User 0

Love0

News

September 8, 2014

Roche’s rheumatoid arthritis drug wins EU approval for extended use | Reuters

Swiss drugmaker Roche Holding AG said on Monday the European Union has approved the use…

Super User 0

Love0

News

September 5, 2014

MedImmune BioNetworking Event for Post-Docs & Professional

WHEN: Thursday, Sept 25th, 2014 From 3:00 to 5:00 PM WHERE: One MedImmune Way Gaithersburg…

Super User 0

Love0

News

September 5, 2014

MIMETAS receives 1.7 million dollar pharma funding for kidney-on-a-chip nephrotoxicity model

MIMETAS, in a consortium with Radboudumc and FHNW, has received 1.6 million USD funding for…

Super User 0

Love0

Janssen Inc. and Johnson & Johnson Innovation establish research collaboration with the University of Toronto – MarketWatch

What Is Amyotrophic Lateral Sclerosis (ALS) or Lou Gehrig’s Disease? – MIT Technology Review

114th Edition – September 9, 2014

BioFund passes $2 million in loans for startups in Southeast Louisiana – NOLA.com

Where Is the Smart Venture Capital Money Going in Digital Health / Health IT?

Capital Buzz: Entrepreneurial brothers create venture capital fund – The Washington Post

Emergent BioSolutions Awarded Contract to Develop a Dry Formulation of NuThrax, a Next Generation Anthrax Vaccine – Seeking Alpha

Roche’s rheumatoid arthritis drug wins EU approval for extended use | Reuters

MedImmune BioNetworking Event for Post-Docs & Professional

MIMETAS receives 1.7 million dollar pharma funding for kidney-on-a-chip nephrotoxicity model

About BioHealth Innovation

Contact

Connect